VISIONPLATFORMABOUTGET IN TOUCH

Genomics
to the Power
of Every Person

What if...

What if checking your epigenetic markers for hereditary conditions would be as easy as taking your temperature?

What if disease markers could be detected anywhere, by anyone, within minutes, without the need to send samples to central labs and wait weeks for results?

What if the genomic insights needed for precision therapeutics and preventive healthcare could be in anybody's hand?

Discover Acorn

The Power of Precision Genomics—Unlocked for Everyone

Discover Acorn

The precision genomics platform built for decentralized, affordable, and automated nanopore genome sequencing at scale.

Our Unique Approach

Solid State Nanopore Gene Sequencing

01  /  Integrated Sequencing Chip
02  /  High-Speed DNA Translocation
03  /  Superior Mechanical & Chemical Stability
04  /  Increased Sensitivity
EASE
Simplicity & Speed
POWER
Comprehensiveness & Precision
LOW COST
Opportunity & Scalability

Speed and Ease for Advantage and Scalability

Acorn genetics
2nd gen
3rd gen
protein nanopore
Long Read Capabilities
10K or Less Cost to Purchase
/
Intuitive, User-Friendly Design
Rapid Turnaround on Results
Durable, Reusable Flow Cell

For People...

Plants...

Pathogens...

... and everything else.

Our Team

World-Class Innovators in 3rd Gen Sequencing

Ana Cornell,
CEO
Thiel Fellowship
Northwestern University
Field Museum
Max Derbyshire,
COO
Northwestern Medicine
Leadership Initiatives
Ryan Abbott,
CTO
Simpson Querrey Institute
Rogers Research Group
Ross Wojcik,
CPO
Northwestern Design Innovation
Jake Turner,
Director of Engineering
Aakaanksha Maddineni,
Director of Research
Conrad Slorer,
Engineer
Our Advisors
Kristin Gleitsmann, PhD
VP of Discovery Research at Veracyte; Former PacBio Manager
Kevin Travers, PhD
SVP at LevitasBio; Former PacBio Manager
Dr. Nathan Gianneschi
International Institute for Nanotechnology
Richard Box
Investor at Hyde Park Angels

Supported by Leading Investors